MANGOCEUTICALS, INC. (MGRX) — SEC Financial Statements & Analysis

MANGOCEUTICALS, INC. (MGRX) is a services-misc health & allied services, nec company, incorporated in TX. MANGOCEUTICALS, INC. trades on Nasdaq as: MGRX. MANGOCEUTICALS, INC. (MGRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, MANGOCEUTICALS, INC. carries a market cap of $6.51M, a P/E ratio of -0.44x, a P/B ratio of 0.52x, a P/S ratio of 20.64x, an enterprise value of $6.32M, and an EV/EBITDA multiple of -0.51x. On profitability, it posts a gross margin of 54.43%, an operating margin of -3916.81%, a net margin of -4698.16%, a Return on Equity (ROE) of -93.24%, a Return on Assets (ROA) of -84.59%, and a Return on Invested Capital (ROIC) of -78.40%. Per share, it reports EPS of $-0.87, diluted EPS of $-0.87, free cash flow per share of $-0.23, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -38.91% year-over-year, net income growth of 0.12% year-over-year, and EPS growth of -41.61% year-over-year. On the balance sheet, it maintains a current ratio of 0.18x, a quick ratio of 0.18x, working capital of $-1.15M, a debt-to-equity ratio of 0.13x, a debt ratio of 0.12, an interest coverage ratio of -129.27x, free cash flow of $-3.89M (TTM), and net debt of $-183.74K. Figures sourced from SEC EDGAR.

Market Cap

$6.51M

P/E TTM

-0.44x

EPS TTM

$-0.87

P/B TTM

0.52x

ROE TTM

-93.24%

ROA TTM

-84.59%

Debt To Equity

0.13x

Free Cash Flow TTM

$-3.89M

Net Revenue TTM Growth 1Y

-38.91%

Data as of 2026-06-30 · Source: SEC EDGAR